FLUTICASONE PROPIONATE
NASAL STEROIDS · CHRONIC NON-ALLERGIC RHINITIS
APOTEX CORP
Drug class
Nasal Steroids
Nasal steroids, more formally designated in regulatory and clinical reference standards as intranasal corticosteroids, are a therapeutic class of topical glucocorticoids formulated for mucosal delivery into the nasal cavity. Read more about Nasal Steroids
137 drugs in this class 54 manufacturers
Drugs in Nasal Steroids
ALLERGY RELIEF (diphenhydramine HCl)
ANTIPARKINSONIAN ANTICHOLINERGIC AGENTS · PARKINSONISM ·+17
TARGET CORP
ALLERGY RELIEF (diphenhydramine HCl)
ANTIPARKINSONIAN ANTICHOLINERGIC AGENTS · PARKINSONISM ·+17
SUNMARK
ALLERGY RELIEF (diphenhydramine HCl)
ANTIPARKINSONIAN ANTICHOLINERGIC AGENTS · PARKINSONISM ·+17
TARGET CORP
ALLERGY RELIEF (diphenhydramine HCl)
ANTIPARKINSONIAN ANTICHOLINERGIC AGENTS · PARKINSONISM ·+17
SUNMARK
ALLERGY RELIEF (loratadine)
ANTIPARKINSONIAN ANTICHOLINERGIC AGENTS · ALLERGIC CONJUNCTIVITIS ·+3
SUNMARK
ALLERGY RELIEF (loratadine)
ANTIPARKINSONIAN ANTICHOLINERGIC AGENTS · ALLERGIC CONJUNCTIVITIS ·+3
TARGET CORP
ALLERGY RELIEF (loratadine)
ANTIPARKINSONIAN ANTICHOLINERGIC AGENTS · ALLERGIC CONJUNCTIVITIS ·+3
HEALTH MART
ALLERGY RELIEF (diphenhydramine HCl)
ANTIPARKINSONIAN ANTICHOLINERGIC AGENTS · PARKINSONISM ·+17
TARGET CORP
Filter & compare in the drug finder →
Opens the drug finder with Nasal Steroids preselected. Add indication or manufacturer filters there.
Nasal steroids, more formally designated in regulatory and clinical reference standards as intranasal corticosteroids, are a therapeutic class of topical glucocorticoids formulated for mucosal delivery into the nasal cavity.
They function primarily through intracellular glucocorticoid receptor binding, which modulates gene transcription to suppress local inflammatory cascades, decrease mucosal edema, inhibit mediator release from inflammatory cells, and diminish nasal hypersensitivity.
This class serves as a first-line therapeutic intervention across upper respiratory inflammatory disorders, most notably seasonal and perennial allergic rhinitis, nonallergic rhinitis, and chronic rhinosinusitis with or without nasal polyps.
-
fda.gov
Nasal steroids, more formally designated in regulatory and clinical reference standards as intranasal corticosteroids, are a therapeutic class of topical glucocorticoids formulated for mucosal delivery into the nasal cavity
-
nih.gov
Nasal steroids, more formally designated in regulatory and clinical reference standards as intranasal corticosteroids, are a therapeutic class of topical glucocorticoids formulated for mucosal delivery into the nasal cavity They function primarily through intracellular glucocorticoid receptor binding, which modulates gene transcription to suppress local inflammatory cascades, decrease mucosal edema, inhibit mediator release from inflammatory cells, and diminish nasal hypersensitivity This class ...
-
drugs.com
Nasal steroids, more formally designated in regulatory and clinical reference standards as intranasal corticosteroids, are a therapeutic class of topical glucocorticoids formulated for mucosal delivery into the nasal cavity
-
nih.gov
They function primarily through intracellular glucocorticoid receptor binding, which modulates gene transcription to suppress local inflammatory cascades, decrease mucosal edema, inhibit mediator release from inflammatory cells, and diminish nasal hypersensitivity
-
rxlist.com
They function primarily through intracellular glucocorticoid receptor binding, which modulates gene transcription to suppress local inflammatory cascades, decrease mucosal edema, inhibit mediator release from inflammatory cells, and diminish nasal hypersensitivity
-
fda.gov
This class serves as a first-line therapeutic intervention across upper respiratory inflammatory disorders, most notably seasonal and perennial allergic rhinitis, nonallergic rhinitis, and chronic rhinosinusitis with or without nasal polyps
-
fda.gov
This class serves as a first-line therapeutic intervention across upper respiratory inflammatory disorders, most notably seasonal and perennial allergic rhinitis, nonallergic rhinitis, and chronic rhinosinusitis with or without nasal polyps
-
nih.gov
This class serves as a first-line therapeutic intervention across upper respiratory inflammatory disorders, most notably seasonal and perennial allergic rhinitis, nonallergic rhinitis, and chronic rhinosinusitis with or without nasal polyps
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.